2012 Fiscal Year Final Research Report
New Treatment Strategies for Inflammatory Bowel Disease using a novel NF-κB inhibitior (DHMEQ)
Project/Area Number |
22591474
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Hokkaido University |
Principal Investigator |
SUZUKI Tomomi 北海道大学, 大学院・医学研究科, 特任准教授 (70374238)
|
Co-Investigator(Kenkyū-buntansha) |
YAMASHITA Kenichiro 北海道大学, 大学院・医学研究科, 特任准教授 (00399940)
|
Project Period (FY) |
2010 – 2012
|
Keywords | 炎症性腸疾患 / 腸管免疫 / NF-κB |
Research Abstract |
A novel NF-κB inhibitor, DHMEQ, strongly ameliorated development of two types of experimental colitis in mice (DSS colitis and TNBS colitis) and DHMEQ appears as a promising candidate for treatment of inflammatory bowel disease. On the otherhand, we explored the development of another stronger NF-κB inhibitor and got3-[(dodecylthiocarbonyl)-methyl]-glutarimide (DTCM-G). We also demonstrated DTCM-G notably attenuated two types of experimental murine models of IBD. We investigated the underlying mechanism in the anti-inflammatory effect of DTCM-G by using RAW264.7 cellsand demonstrated that the inhibition of AKT and GSK-3β activations were related with theanti-inflammatory effect of DTCM-G.
|
-
[Journal Article] A novel NF-kB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice2012
Author(s)
Funakoshi T, Yamashita K, Ichikawa N, Fukai M, Suzuki T, Goto R, Oura T, Kobayashi N, Katsurada T, Ichihara S, Ozaki M, Umezawa K, Todo S
-
Journal Title
Journal of Crohn's and Colitis
Volume: 6
Pages: 215-225
Peer Reviewed
-
[Presentation] A Novel Anti-Inflammatory Agent, 3-[(dodecylthiocarbonyl)-methyl]-glutar imide, Ameliorates Murine Models of Inflammatory Bowel Disease2011
Author(s)
Ichikawa N, Yamashita K, Funakoshi T, Shibasaki S, Ichihara S, Kobayashi N, Koshizuka Y, Zaitsu M, Fukai M, Suzuki T, Ozaki M, Umezawa K, Todo S
Organizer
Digestive Disease Week
Place of Presentation
McCormick Place, Chicago, US
Year and Date
20110507-10
-
[Presentation] A Novel Anti-Inflammatory Agent,3-[(dodecylthiocarbonyl)-methyl]-glutar imide, Ameliorates Murine Models of Inflammatory Bowel Disease2010
Author(s)
Ichikawa N, Yamashita K, Funakoshi T, Ichihara S, Kobayashi N, Koshizuka Y, Zaitsu M, Ogura M, Yoshida T, Tsunetoshi Y, Fukai M, Suzuki T, Ozaki M, Umezawa K, Todo S
Organizer
The 25th ISUCRS Biennial Congress
Place of Presentation
Palazzo della Cultura e dei Congressi, Bologna, Italy
Year and Date
20100624-26
-
[Presentation] A Novel Anti-Inflammatory Agent, DTCM-Glutarimide2010
Author(s)
Ichikawa N, Yamashita K, Funakoshi T, Shibasaki S, Ichihara S, Fukai M, Suzuki T, Ozaki M, Umezawa K, Todo S
Organizer
AttenuatesExperimental Colitis in Mice Digestive Disease Week
Place of Presentation
Morial Convention Center, New Orleans, US
Year and Date
20100501-05
-
[Presentation] A novel NF-□B i nhi bit or , DHMEQ, ameliorates inflammatory colonic injuries in mice.2010
Author(s)
Funakoshi T, Yamashita K, Ichikawa N,Kobayashi N, Fukai M, Suzuki T, Goto R, Oura T, Katsurada T, Ozaki M, Umezawa K, Todo S.
Organizer
Digestive Disease Week 2010
Place of Presentation
Morial ConventionCenter, New Orleans, US
Year and Date
20100501-05
-
-
-
[Presentation] The therapeutic effect of a novelNF-□B inhibitor, DHMEQ, on experimentalcolitis in mice.2010
Author(s)
Funakoshi T, Yamashita K, Ichikawa N, Kobayashi N, Fukai M, Suzuki T, Goto R, Oura T, Katsurada T, Ozaki M, Umezawa K, Todo S.
Organizer
The 24th ISUCRS Biennial Congress
Place of Presentation
COEX, Seoul, Korea
Year and Date
20100319-23
-
-